| 2024-06-10 | Sale | Cytokinetics, Incorporated CYTK | director | 2,000 0.0017% | $52.07 | $104,140 | -1.99% | |
| 2024-06-10 | Sale | Veracyte, Inc. VCYT | director | 3,870 0.0049% | $20.32 | $78,634 | +4.29% | |
| 2024-05-28 | Sale | Veracyte, Inc. VCYT | director | 1,539 0.002% | $21.00 | $32,319 | -0.37% | |
| 2023-10-31 | Sale | Intellia Therapeutics, Inc. NTLA | director | 265 0.0003% | $23.90 | $6,334 | +5.21% | |
| 2023-07-31 | Sale | Intellia Therapeutics, Inc. NTLA | director | 265 0.0003% | $42.33 | $11,217 | -34.37% | |
| 2023-07-07 | Sale | Cytokinetics, Incorporated CYTK | director | 2,000 0.0021% | $34.12 | $68,235 | +39.28% | |
| 2023-07-06 | Sale | Intellia Therapeutics, Inc. NTLA | director | 1,867 0.0021% | $39.30 | $73,373 | -27.66% | |
| 2023-06-16 | Sale | Veracyte, Inc. VCYT | director | 5,893 0.0083% | $26.44 | $155,786 | -6.63% | |
| 2023-05-30 | Sale | Veracyte, Inc. VCYT | director | 1,539 0.0022% | $25.91 | $39,875 | -2.96% |